Anandamide - A new look on fatty acid ethanolamides

Journal of Lipid Mediators and Cell Signalling

Volumn 15, Issue 1, 1996, Pages 49-67

  Berdyshev, Evguenii V ^a   Boichot, Elisabeth ^b   Lagente, Vincent ^b  

^a INSTITUTE OF MARINE BIOLOGY   (Russian Federation)

^b UNIVERSITÉ DE RENNES 1   (France)

Author keywords

anandamide; cannabinoid receptors; cannabinoids; fatty acid ethanolamides

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; ANANDAMIDE; CANNABINOID; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR ANTAGONIST; DRONABINOL; ETHANOLAMINE DERIVATIVE; FATTY ACID DERIVATIVE; PALMIDROL; RIMONABANT;

ARACHIDONIC ACID METABOLISM; CENTRAL NERVOUS SYSTEM; HUMAN; LYMPHOCYTE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; REVIEW;

EID: 0030498610     PISSN: 09297855     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0929-7855(96)00548-2     Document Type: Article

References (105)

1. Aloe L., Leon A. and Levi-Montalcini R. (1993) A proposed autocoid mechanism controlling mastocyte behavior. Agents Actions 39, C145-C147.
2. Ambrosini A., Bertoli, E., Tanfani, F., Wozniak, M., Wypych, Z. and Zolese, G. (1993a) Effect of N-acylethanolamines with different acyl-chains on DPPC multilamellar liposomes. Chem. Phys. Lipids 65, 165-169.
3. Ambrosini, A., Bertoli, E., Mariani, P., Tanfani, F., Wozniak, M. and Zolese, G. (1993b) N-acylethanolamines as membrane topological stress compromising agents. Biochim. Biophys. Acta 1148, 351-355.
4. Aneja, R., Chadha, J.S. and Knaggs, J.A. (1969) N-acylphosphatidylethanolamines: occurrence in nature, structure and stereochemistry. Biochem. Biophys. Res. Commun. 36, 401-406.
5. Bayewitch, M., Avidorreiss, T., Levy, R., Barg, J., Mechoulam, R. and Vogel, Z. (1995) The peripheral cannabinoid receptor-adenylate cyclase inhibition and G protein coupling. FEBS Lett. 375, 143-147.
6. Berdyshev, E.V. and Vaschenko, M.A. (1994) The influence of platelet activating factor and lipid preparation KPS on the sperm fertility of sea urchin Strongylocentrotus intermedius subjected to deep freezing. Probl. Criobiol. 2, 44-50 (in Russian).
7. Bomstein, R.A. (1965) A new class of phosphatides isolated from soft wheat flour. Biochem. Biophys. Res. Commun. 21, 49-54.
8. Bouaboula, M., Rinaldi, M., Carayon, P. et al. (1993) Cannabinoid-receptor expression in human-leukocytes. Eur. J. Biochem. 214, 173-180.
9. 2+ release from mitochondria. J. Biol. Chem. 260, 105-113.
10. Burstein, S.H. and Hunter, S.A. (1995) Stimulation of anandamide biosynthesis in N-18TG2 neuroblastoma cells by Δ9-tetrahydrocannabinol (THC). Biochem. Pharmacol. 49, 855-858.
11. Cabral, G.A. and Fischer-Stenger, K. (1994) Inhibition of macrophage inducible protein expression by Δ9-tetrahydrocannabinol. Life Sci. 54, 1831-1844.
12. Cabral, G.A., Toney, D.M., Fischer-Stenger, K., Harrison, M.P. and Marciano-Cabral, F. (1995) Anandamide inhibits macrophage-mediated killing of tumor necrosis factor-sensitive cells. Life Sci. 56, 2065-2072.
13. Chang, M.C., Berkery, D., Schuel, R. et al. (1993) Evidence for a cannabinoid receptor in sea-urchin sperm and its role in blockade of the acrosome reaction. Mol. Reprod. Dev. 36, 507-516.
14. Childers, S.R., Sexton, T. and Roy, M.B. (1994) Effects of anandamide on cannabinoid receptors in rat brain membranes. Biochem. Pharmacol. 47, 711-715.
15. Coburn, A.F., Graham, C.E. and Hahinger J. (1954) Effect of egg yolk in diets on anaphylactic arthritis (passive Arthus phenomenon) in the guinea pig. J. Exp. Med. 100, 425-435.
16. Crawley, J.N. Corwin R.L., Robinson J.K. Felder C.C., Devane W.A. and Axelrod J. (1993). Anandamide, an endogenous ligand of the cannabinoid receptor, induces hypomotility and hypothermia in-vivo in rodents. Pharmacol. Biochem. Behav. 46, 967-972.
17. Das, S.K., Paria, B.C., Chakraborty, I. and Dey, S.K. (1995) Cannabinoid ligand-receptor signaling in the mouse uterus. Proc. Natl. Acad. Sci. USA 92, 4332-4336.
18. Dawson, R.M.C., Clarke, N. and Quarles, R.H. (1969) N-acylphosphatidylethanolamine, a phospholipid that is rapidly metabolized during the early germination of pea seeds. Biochem. J. 114, 265-270.
19. Derocq, J.M., Segui, M., Marchand, J., Lefur, G. and Casellas, P. (1995) Cannabinoids enhance human B-cell growth at low nanomolar concentrations. FEBS Lett. 369, 177-182.
20. Desarnaud, F., Cadas, H. and Piomelli, D. (1995) Anandamide amidohydrolase activity in rat brain microsomes - identification and partial characterization. J. Biol. Chem. 270, 6030-6035.
21. Devane, W.A. and Axelrod, J. (1994) Enzymatic synthesis of anandamide, an endogenous ligand for the cannabinoid receptor, by brain membranes. Proc. Natl. Acad. Sci. USA 91, 6698-6701.
22. Devane, W.A., Dysarz, F.A., Johnson, M.R., Melvin, L.S. and Hewlett, A.C. (1988) Determination and characterization of a cannabinoid receptor in rat brain. Mol. Pharmacol. 34, 605-613.
23. Devane, W.A., Hanus, L., Breuer, A. et al. (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258, 1946-1949.
24. Dewey W.L. (1986) Cannabinoid pharmacology. Pharmacol. Rev. 38, 151-178.
25. Di Marzo, V., Fontana, A., Cadas, H. et al. (1994) Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature 372, 686-691.
26. Ellis, E.F. and Moore, S. (1994) Anandamide and A9-THC cause cerebral arteriolar dilation by a cyclooxygenase-dependent mechanism. FASEB J. 8, A557.
27. Epps, D.E., Schmid, P.C., Natarajan, V. and Schmid, H.H.O. (1979) N-acylethanolamine accumulation in infarcted myocardium. Biochem. Biophys. Res. Commun. 90, 628-633.
28. Epps, D.E., Natarajan, V., Schmid, P.C. and Schmid, H.H.O. (1980) Accumulation of N-acylethanolamine glycerophospholipids in infarcted myocardium. Biochim. Biophys. Acta 618, 420-430.
29. Epps, D.E., Mandel, F. and Schwartz, A. (1982a) The alteration of rabbit skeletal sarcoplasmic-reticulum function by N-acylethanolamine, a lipid associated with myocardial-infarction. Cell Calcium 3, 531-543.
30. 2+ release from mitochondria by N-acylethanolamines, a class of lipids, synthesized in ischemic heart-tissue. J. Biol. Chem. 257, 1383-1391.
31. Epps, D.E., Grupp, I.L., Grupp, G. and Schwartz, A. (1983) Protective effects of N-acylethanolamines, an endogenous class of lipid amides, on hypoxic guinea-pig heart. IRCS Med. Sci. 10, 899-900.
32. Epps, D.E. and Cardin, A.D. (1987) The interaction of N-oleoylethanolamine with phospholipid-bilayers. Biochim. Biophys. Acta 903, 533-541.
33. Facci, E., Dal Toso, R., Romanello, S., Buriani, A., Skaper, S.D. and Leon, A. (1995) Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide. Proc, Natl. Acad. Sci. USA 92, 3376-3380.
34. Felder, C.C., Briley, E.M., Axelrod, J., Simpson, J.T., Mackie, K. and Devane, W.A. (1993) Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction. Proc. Natl. Acad. Sci. USA 90, 7656-7660.
35. Felder, C.C., Joyce, K.E., Briley, E.M. et al. (1995) Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors. Mol. Pharmacol. 48, 443-450.
36. Fischer-Stenger, K., Pettit, D.A.D. and Cabral, G.A. (1993) Δ9-tetrahydrocannabinol inhibition of tumor-necrosis-factor-alpha: suppression of post-translational events. J. Pharmacol. Exp. Ther. 267, 1558-1565.
37. Fragkakis G., Probonas K., Giannikou P., Yiannakakis N. and Wenger T. (1995) The effects of anandamide (endogen cannabinoid) on prostaglandin synthesis in pregnant rat. Neuroendocrinol. Lett, 17, 271-279.
38. Fride, E. and Mechoulam, R. (1993) Pharmacological activity of the cannabinoid receptor agonist, anandamide. a brain constituent. Eur. J. Pharmacol. 231, 313-314.
39. Fride, E., Barg, J., Levy, R. et al. (1995) Low doses of anandamide inhibit pharmacological effects of Δ9-tetrahydrocannabinol. J. Pharmacol. Exp. Ther. 272, 699-707.
40. Galiegue, S., Mary, S., Marchand, J. et al. (1995) Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur. J. Biochem. 232, 54-61.
41. Ganley, O.H., Graessle, O.E. and Robinson, H.J. (1958) Anti-inflammatory activity of compounds obtained from egg yolk, peanut oil and soybean lecithin. J. Lab. Clin. Med. 51, 709-714.
42. Ganley, O.H. and Robinson, H.J. (1959) Anti-anaphylactic and anti-serotonin activity of a compound from egg yolk, peanut oil and soy bean lecithin. J. Allergy 30, 415-419.
43. Gérard, C.M., Mollereau, C., Vassart, G. and Parmentier, M. (1991) Molecular-cloning of a human cannabinoid receptor which is also expressed in testis. Biochem. J. 279, 129-134.
44. Gray, G.M. (1976) Phosphatidyl-(N-acyl)-ethanolamine - a lipid component of mammalian epidermis. Biochim. Biophys. Acta 431, 1-8.
45. Gulaya N.M., Melnik A.A., Balkov D.I., Volkov G.L., Vysotskiy M.V. and Vaskovsky V.E. (1993) The effect of long-chain N-acylethanolamines on some membrane-associated functions of neuroblastoma C1300 N18 cells. Biochim. Biophys. Acta 1152, 280-288.
46. Hack, M.H. and Helmy, P.M. (1975) Bis-phosphatidic acid plasmalogen in brain of ania cava and its correlation with the infarct plasmalogen and the cardiolipin (diphosphatidylglycerol) series of hosphatides. Comp. Biochem. Physiol. 52C, 139-145.
47. Hampson A.J., Hill W.A.G., Zan-Phillips M. et al. (1995) Anandamide hydroxylation by brain lipoxygenase: metabolite structures and potencies at the cannabinoid receptor. Biochim. Biophys. Acta 1259, 173-179.
48. Howlett A.C. (1995) Pharmacology of cannabinoid receptors. Annu. Rev. Pharmacol. Toxicol. 35, 607-634.
49. Kára, J., Borovicka, M., Liebl, V., Smoliková, J. and Ubik, K. (1986) A novel non-toxic alkyl-phospholipid with selective antitumor activity, plasmanyl-(N-acyl)-ethanolamine (PNAE), isolated from degenerating chick embryonal tissues and from an anticancer biopreparation cACPL. Neoplasma 33, 187-205.
50. Klein, T.W., Newton, C. and Friedman, H. (1994) Resistance to Legionella-pneumophila suppressed by the marijuana component, tetrahydrocannabinol. J. Infect. Dis. 169, 1177-1179.
51. Knauff, H.G. and Böck, F. (1961) On the free amino acids and the ethanolamine in the brain of normal rats, as well as on the behavior of these substances after experimental insulin hypoglycemia. J. Neurochem. 6, 171-182.
52. Kruszka, K.K. and Grossi, R.W. (1994) The ATP-independent and CoA-independent synthesis of arachidonoylethanolamide - a novel mechanism underlying the synthesis of the endogenous ligand of the cannabinoid receptor. J. Biol. Chem. 269, 14 345-14 348.
53. Kuehl, F.A., Jr., Jacob, T.A., Ganley O.H., Ormond, R.E. and Meisinger, M.A.P. (1957) The identification of N-(2-hydroxyethyl)-palmitamide as a naturally occurring anti-inflammatory agent. J. Am. Chem. Soc. 79, 5577-5578.
54. Kusher, D.I., Dawson, L.O., Taylor, A.C. and Djeu, J.Y. (1994) Effect of the psychoactive metabolite of marijuana, delta(9)-tetrahydrocannabinol (THC), on the synthesis of tumor-necrosis-factor by human large granular lymphocytes. Cell. Immunol. 154, 99-108.
55. Long, D.A. and Martin, A.J.P. (1956) Factor in arachis oil depressing sensitivity to tuberculin in B.C.G.-infected guinea pigs. Lancet 1, 464-466.
56. Lynn A.B. and Herkenham M. (1994) Localization of cannabinoid receptors and nonsaturable high-density cannabinoid binding sites in peripheral tissues of the rat: implications for receptor-mediated immune modulations by cannabinoids. J. Pharmacol. Exp. Ther. 268, 1612-1623.
57. Mackie, K., Devane, W.A. and Hille, B. (1993) Anandamide, an endogenous cannabinoid, inhibits calcium currents as a partial agonist in N18 neuroblastoma cells. Mol. Pharmacol. 44, 498-503.
58. Mackie, K., Lai, Y., Westenbroek, R. and Mitchell, R. (1995) Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT-20 cells transfected with rat brain cannabinoid receptor. J. Neurosci. 15, 6552-6561.
59. Matsuda L.A., Lolait S.J., Brownstein M.J., Young A.C. and Bonner T.I. (1990) Structure of cannabinoid receptor and functional expression of the cloned cDNA, Nature 346, 561-564.
60. Matsumoto, M. and Miwa, M. (1973) Study on new phospholipid-N-acyl-l-alkyl glycerophosphorylethanolamine, from bovine erythrocytes. Biochim. Biophys. Acta 296, 350-364.
61. Mechoulam, R., Hanus L. and Martin B.R. (1994) Search for endogenous ligands of the cannabinoid receptor. Biochem. Pharmacol. 48, 1537-1544.
62. Munro, S., Thomas, K.L. and Abu-Shaar, M. (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature 365. 61-65.
63. Natarajan, V., Reddy, P.V., Schmid, P.C. and Schmid, H.H.O. (1981) On the biosynthesis and metabolism of N-acylethanolamine phospholipids in infarcted dog heart. Biochim. Biophys. Acta 664, 445-448.
64. Natarajan, V., Reddy, P.V., Schmid, P.C. and Schmid, H.H.O. (1982) N-acylation of ethanolamine phospholipids in canine myocardium. Biochim. Biophys. Acta 712, 342-355.
65. Natarajan, V., Schmid, P.C., Reddy, P.V., Zuzarte-Augustin, M.L. and Schmid, H.H.O. (1983) Biosynthesis of N-acylethanolamine phospholipids by dog brain preparations. J. Neurochem. 41, 1303-1312.
66. Natarajan, V., Schmid, P.C., Reddy, P.V. and Schmid, H.H.O. (1984) Catabolism of N-acylethanolamine phospholipids by dog brain preparations. J. Neurochem. 42, 1613-1619.
67. Natarajan, V., Schmid, P.C., Reddy, P.V., Zuzarte-Augustin, M.L. and Schmid, H.H.O. (1985) Occurrence of N-acylethanolamine phospholipids in fish brain and spinal cord. Biochim. Biophys. Acta 835, 426-433.
68. Natarajan, V., Schmid, P.C. and Schmid, H.H.O. (1986) N-acylethanolamine phospholipid metabolism in normal and ischemic rat brain. Biochim. Biophys. Acta 878. 32-41.
69. Nemer, M.J. and Elwyn, D. (1960) The conversion of serine to ethanolamine and its derivatives in the rat. J. Biol. Chem. 235, 2070-2074.
70. Newton, C.A., Klein, T.W. and Friedman, H. (1994) Secondary immunity to Legionella-pneumophila and Th1 activity are suppressed by Δ9-tetrahydrocannabinol injection. Infect. Immun. 62, 4015-4020.
71. 14C] as a substrate for anandamide amidase. Life Sci. 56, 1999-2005.
72. Paria, B.C., Das, S.K. and Dey, S.K. (1995) The preimplantation mouse embryo is a target for cannabinoid ligand-receptor signaling, Proc. Natl. Acad. Sci. USA 92, 9460-9464.
73. Pate, D.W., Jarvinen, K., Urtti, A., Jarho, P. and Jarvinen, T. (1995) Ophtalmie arachidonoylethanolamide decreases intraoccular pressure in normotensive rabbits. Curr. Eye Res. 14, 791-797.
74. Perlik, F., Elis, F. and Rašková, H. (1971a) Anti-inflammatory activity of N-(2-hydroxyethyl)palmitamide. Acta Physiol. Acad. Sci. Hung. 39, 123-124.
75. Perlík, F., Elis, F. and Rašková, H. (1971b)) Anti-inflammatory properties of N-(2-hydroxyethyl)palmitamide. Acta Physiol. Acad. Sci. Hung. 39, 395-400.
76. Perlík, F., Krejci, J, Elis, F., Pekárek J. and Svejcar, J. (1973) The effect of N-(2-hydroxyethyl)palmitamide on delayed hypersensitivity in guinea-pig. Experientia 29, 67-68.
77. Pinto J.C., Potié F., Rice K.C., Boring D., Johnson M.R., Evans D.M., Wilken G.H., Cantrell C.H. and Howlett A.C. (1994) Cannabinoid receptor binding and agonist activity of amides and esters of arachidonic acid. Mol. Pharmacol. 46, 516-522.
78. Rašková, H. and Mašek, K. (1967) Nouvelles possibilités d'augmentation de la résistance non-spécifique. Therapie 22, 1241-1246.
79. Rašková, H., Mašek, K, and Linet, O. (1972) Nonspecific resistance induced by palmitoylethanolamide. Toxicon 10, 485-490.
80. Reddy, P.V., Natarajan, V., Schmid, P.C. and Schmid, H.H.O. (1983a) N-acylation of dog heart ethanolamine phospholipids by transacylase activity. Biochim. Biophys. Acta 750, 472-480.
81. Reddy, P.V., Schmid, P.C., Natarajan, V. and Schmid, H.H.O. (1983b) The role of cardiolipin as an acyl donor in dog heart N-acylethanolamine phospholipid biosynthesis. Biochim. Biophys. Acta 751, 241-246.
82. Reddy, P.V., Schmid, P.C., Natarajan, V., Muramatsu, T. and Schmid, H.H.O. (1984) Properties of canine myocardial phosphatidylethanolamine N-acyltransferase. Biochim. Biophys. Acta 795, 130-136.
83. Romero, J., Garcia, L., Cebeira, M., Zadrozny, D., Fernandezruiz, J.J. and Ramos, J.A. (1995) The endogenous cannabinoid receptor ligand, anandamide, inhibits the motor behavior - role of nigrostriatal dopaminergic neurons. Life Sci. 56, 2033-2040.
84. Schmid, P.C. and Schmid, H.H.O. (1987) N-acylation of ethanolamine phospholipids by acyl transfer does not involve hydrolysis. Biochim. Biophys. Acta 922, 398-400.
85. Schmid, P.C., Natarajan, Y., Reddy, P.V. and Schmid, H.H.O. (1983) Metabolism of N-acylethanolamine phospholipids by a mammalian phosphodiesterase of the phospholipase-D type. J. Biol. Chem. 258, 9302-9306.
86. Schmid, P.C., Schmid, H.H.O. and Zuzarte-Augustin, M.L. (1985) Properties of rat-liver N-acylethanolamine amidohydrolase. J. Biol. Chem. 260, 14 145-14 149.
87. Schmid, H.H.O., Schmid, P.C. and Natarajan, V. (1990) N-acylated glycerophospholipids and their derivatives. Prog. Lipid Res. 29, 1-43.
88. Schuel, H., Schuel, R., Zimmemnan, A.M. and Zimmerman, S. (1987) Cannabinoids reduce fertility of sea-urchin sperm. Biochem. Cell Biol. 65, 130-136.
89. Schuel, H., Berkery, D., Schuel, R., Chang, M.C., Zimmerman, A.M. and Zimmerman, S. (1991) Reduction of the fertilizing-capacity of sea-urchin sperm by cannabinoids derived from marijuana. 1. Inhibition of the acrosome reaction induced by egg jelly. MoI. Reprod, Dev. 29, 51-59.
90. Schuel, H., Goldstein, E., Mechoulam, R, Zimmerman, A.M. and Zimmerman, S. (1994) Anandamide (arachidonylethanolamide), a brain cannabinoid receptor agonist, reduces sperm fertilizing capacity in sea urchins by inhibiting the acrosome reaction. Proc. Natl. Acad. Sci. USA 91, 7678-7682.
91. Slipetz D.M., O'Neill G.P., Favreau L. et al. (1995) Activation of the human peripheral cannabinoid receptor results in inhibition of adenylate cyclase. Mol. Pharmacol. 48, 352-361.
92. Smith, P.B., Compton, D.R., Welch, S.P., Razdan, R.K., Mechoulam, R. and Martin, B.R. (1994) The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice. J. Pharmacol. Exp. Ther. 270, 219-227.
93. Somerharju, P. and Renkonen, O. (1979) Glycerophospho-(N-acyl)-ethanolamine lipids in degenerating BHK cells. Biochim. Biophys. Acta 573, 83-89.
94. Souilhac, J., Poncelet, M., Rinaldicarmona, M., Lefur, G. and Soubrie, P. (1995) Intrastriatal injection of cannabinoid receptor agonists induced turning behavior in mice. Pharmacol. Biochem. Behav. 51, 3-7.
95. 2+-dependent transacylase and phosphodiesterase activities. Biochem. Biophys. Res. Commun. 218, 113-117.
96. Svec, P., Béderová, E. and Svec, J. (1975a) Influence of N-(2-hydroxyethyl)-palmitamide on virus-induced sarcoma in chickens and Raucher leukemia in mice. Neoplasma 22, 519-524.
97. Svec, P., Béderová, E. and Svec, J. (1975b) Effect of long-term administration of N-(2-hydroxyethyl)palmitamide on chemotherapy of RBA rat leukemia. Neoplasma 22, 625-630.
98. Trisler, K. and Specter, S. (1994) Δ9-tetrahydrocannabinol treatment results in a suppression of interleukin-2-induced cellular activities in human and murine lymphocytes. Int. J. Immunopharmacol. 16, 593-597.
99. Varga, K., Lake, K., Martin, B.R. and Kunos, G. (1995) Novel antagonist implicates the CBI cannabinoid receptor in the hypotensive action of anandamide. Eur. J. Pharmacol. 278, 279-283.
100. Venance. L., Piomelli, D., Glowinski, J. and Giaume, C. (1995) Inhibition by anandamide of GAP junctions and intercellular calcium signaling in striatal astrocytes, Nature 376, 590-594.
101. Vogel, Z., Barg, J., Levy, R., Saya, D., Heldman, E. and Mechoulam, R. (1993) Anandamide, a brain endogenous compound, interacts specifically with cannabinoid receptors and inhibits adenylate cyclase. J. Neurochem. 61, 352-355.
102. Wenger, T., Toth, B. and Martin, B.R. (1995) Effects of anandamide (endogenous cannabinoid) on anterior pituitary hormone secretion in adult ovariectomized rats. Life Sci. 56, 2057-2063.
103. Wiley, J., Balster, R. and Martin, B. (1995) Discriminative stimulus effects of anandamide in rats. Eur. J. Pharmacol. 276, 49-54.
104. Zheng, Z.M. and Specter, S. (1994) Suppression by Δ9-tetrahydrocannabinol of lipopolysaccharide-induced and intrinsic tyrosine phosphorylation and protein expression in mouse peritoneal-macrophages. Biochem. Pharmacol. 47, 2243-2252.
105. Zhu, W.G., Newton C., Daaka, Y., Friedman, H. and Klein, T.W. (1994) Δ9-tetrahydrocannabinol enhances the secretion of interleukin-1 from endotoxin-stimulated macrophages. J. Pharmacol. Exp. Ther. 270, 1334-1339.